CCDC58P5

Across TCGA pan-cancer cohorts, CCDC58P5 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CCDC58P5’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where CCDC58P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCDC58P5 is over-expressed in tumor, although a few such as THCA and LIHC show the opposite, repressed pattern.

BLCA, STAD, and THCA are the cancer types where CCDC58P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC58P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.159	.007	5	view →
STAD	All	II,III,IV	+0.211	.019	4	view →
THCA	Male	IV	−0.173	<.001	2	view →
PRAD	All	All	+0.102	.024	2	view →
LIHC	Female	II,III,IV	−0.049	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CCDC58P5–BLCA

Open the BLCA breakdown →